Level Four Advisory Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
Level Four Advisory Services's JAZZ Position: Q1 2026 in Review
Level Four Advisory Services increased its Jazz Pharmaceuticals (JAZZ) stake by 0.2% in Q1 2026, buying an estimated $1.22K and bringing the position to 3,471 shares worth $656K. The position accounts for 0.02% of the portfolio, ranked #517.
Level Four Advisory Services first reported a position in JAZZ in Q4 2016 and has held it in 8 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Level Four Advisory Services held 3,471 shares of Jazz Pharmaceuticals worth $656K as of Q1 2026.
- Level Four Advisory Services bought 7 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.22K.
- Jazz Pharmaceuticals made up 0.02% of Level Four Advisory Services's portfolio in Q1 2026, its #517 holding.
- Level Four Advisory Services first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 8 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Level Four Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.